Ascent Raising Series A

Ascent Therapeutics Inc., a Sherborn, Mass.-based drug development startup focused on cancer and inflammatory diseases, has secured $8 million of a $19 million Series A round according to a regulatory filing. Backers include Healthcare Ventures, Novartis BioVentures and TVM.